Subcutaneous and sublingual immunotherapy for seasonal allergic rhinitis: A systematic review and indirect comparison

Journal of Allergy and Clinical Immunology

Volumn 131, Issue 5, 2013, Pages 1361-1366

  Dretzke, Janine ^a   Meadows, Angela ^a   Novielli, Nicola ^a   Huissoon, Aarnoud ^b   Fry Smith, Anne ^a   Meads, Catherine ^c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^c BRUNEL UNIVERSITY   (United Kingdom)

Author keywords

Allergic rhinitis; indirect comparison; meta analysis; meta regression; subcutaneous immunotherapy; sublingual immunotherapy; systematic review

Indexed keywords

ALLERGEN; PLACEBO;

ARTICLE; CLINICAL EFFECTIVENESS; COMPARATIVE EFFECTIVENESS; DRUG WITHDRAWAL; HAY FEVER; HUMAN; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SUBCUTANEOUS IMMUNOTHERAPY; SUBLINGUAL IMMUNOTHERAPY; SYSTEMATIC REVIEW; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, SUBLINGUAL; ADULT; ALLERGENS; CHILD; DESENSITIZATION, IMMUNOLOGIC; DOUBLE-BLIND METHOD; HUMANS; INJECTIONS, SUBCUTANEOUS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGRESSION ANALYSIS; RHINITIS, ALLERGIC, SEASONAL; TREATMENT OUTCOME;

EID: 84876901228     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2013.02.013     Document Type: Article

References (35)

1. S.J. Arbes Jr., P.J. Gergen, L. Elliott, and D.C. Zeldin Prevalences of positive skin test responses to 10 common allergens in the US population: results from the third National Health and Nutrition Examination Survey J Allergy Clin Immunol 116 2005 377 383
2. A. Fiocchi, and A.T. Fox Preventing progression of allergic rhinitis: the role of specific immunotherapy Arch Dis Child Educ Pract Ed 96 2011 91 100
3. J.A. Burgess, E. Haydn-Walters, G.B. Byrnes, M.C. Matheson, M.A. Jenkins, and C.L. Wharton Childhood allergic rhinitis predicts asthma incidence and persistence to middle-age: a longitudinal study J Allergy Clin Immunol 120 2007 863 869
4. P. White, H. Smith, N. Baker, W. Davis, and A. Frew Symptom control in patients with hay fever in UK general practice: how well are we doing and is there a need for allergen immunotherapy? Clin Exp Allergy 28 1998 266 270
5. Allergy UK. Night and day. Every day report. A report based on research amongst people with allergic rhinitis. Available at: http://www.allergyuk.org/ download.aspx?File=leaflets/Night-and-Day-Report.pdf. Accessed Jun 8, 2011.
6. S.M. Walker, S.R. Durham, S.J. Till, G. Roberts, C.J. Corrigan, and S.C. Leech BSACI guidelines. Immunotherapy for allergic rhinitis Clin Exp Allergy 41 2011 1177 1200
7. L. Cox, H. Nelson, R. Lockey, C. Calabria, T. Chacko, and I. Finegold Allergen immunotherapy: a practice parameter third update J Allergy Clin Immunol 127 suppl 2011 S1 S55
8. M. Okuda A long-term follow-up study after discontinuation of immunotherapy for Japanese cedar pollinosis Arerugi 55 2006 655 661
9. P.A. Eng, M. Borer-Reinhold, I.A.F.M. Heijnen, and H.P.E. Gnehm Twelve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood Allergy 61 2006 198 201
10. S.R. Durham, S.M. Walker, E.M. Varga, M.R. Jacobson, F. O'Brien, and W. Noble Long-term clinical efficacy of grass-pollen immunotherapy N Engl J Med 341 1999 468 475
11. S.R. Durham, W. Emminger, A. Kapp, J.G.R. deMonchy, S. Rak, and G.K. Scadding SQ-standardised sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial J Allergy Clin Immunol 129 2012 717 725.e5
12. G.H. Vance, S. Goldring, J.O. Warner, H. Cox, B. Sihra, and S. Hughes A national audit of pollen immunotherapy for children in the United Kingdom: patient selection and programme safety Clin Exp Allergy 41 2011 1313 1323
13. M.A. Calderon, B. Alves, M. Jacobson, B. Hurwitz, A. Sheikh, and S. Durham Allergen injection immunotherapy for seasonal allergic rhinitis Cochrane Database Syst Rev 1 2007 CD001936
14. S. Radulovic, M. Calderon, D. Wilson, and S. Durham Sublingual immunotherapy for allergic rhinitis Cochrane Database Syst Rev 12 2010 CD002893
15. The Cochrane Collaboration. Cochrane handbook for systematic reviews of interventions 2008 Wiley-Blackwell Chichester
16. Ottawa Hospital Research Institute (OHRI). PRISMA. Transparent reporting of systematic reviews and meta-analyses. Available at: http://www.prisma- statement.org/. Accessed September 6, 2012.
17. J.A.C. Sterne, M. Egger, D. Moher Cochrane Bias Methods Group Addressing reporting biases J.P.T. Higgins, S. Green, Cochrane handbook for systematic reviews of interventions 2008 Wiley-Blackwell Chichester 297 333
18. Review Manager (RevMan) [Computer program]. Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
19. H.J. Schunemann, A.D. Oxman, G.E. Vist, J.P.T. Higgins, J.J. Deeks, and P. Glasziou Interpreting results and drawing conclusions J.P.T. Higgins, S. Green, Cochrane handbook for systematic reviews of interventions 2008 Wiley-Blackwell Chichester 359 387
20. The BUGS project. Available at: www.mrc-bsu.cam.ac.uk/bugs/winbugs/ dicpage.shtml#q9. Accessed February 29, 2012.
21. S. Donegan, P. Williamson, C. Gamble, and C. Tudur-Smith Indirect comparisons: a review of reporting and methodological quality PLoS ONE 5 2010 e11054
22. P. Kuna, J. Kaczmarek, M. Kupczyk, P. Kuna, J. Kaczmarek, and M. Kupczyk Efficacy and safety of immunotherapy for allergies to Alternaria alternata in children J Allergy Clin Immunol 127 2011 502 508
23. M.S. Khinchi, L.K. Poulsen, F. Carat, C. Andre, A.B. Hansen, and H.J. Malling Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study Allergy 59 2004 45 53
24. M.T. Ventura, A. Carretta, R.A. Tummolo, R. Buquicchio, A. Arsieni, and N. Murgia Clinical data and inflammation parameters in patients with cypress allergy treated with sublingual swallow therapy and subcutaneous immunotherapy Int J Immunopathol Pharmacol 22 2009 403 413
25. M. Mauro, M. Russello, C. Incorvaia, G.B. Gazzola, G. Di Cara, and F. Frati Comparison of efficacy, safety and immunologic effects of subcutaneous and sublingual immunotherapy in birch pollinosis: a randomized study Eur Ann Allergy Clin Immunol 39 2007 119 122
26. T. Quirino, E. Iemoli, E. Siciliani, S. Parmiani, and F. Milazzo Sublingual versus injective immunotherapy in grass pollen allergic patients: a double blind (double dummy) study Clin Exp Allergy 26 1996 1253 1261
27. Grazax Asthma Prevention (GAP). Available at: http://clinicaltrials.gov/ ct2/show/NCT01061203. Accessed October 12, 2011.
28. L.M. DuBuske, A.J. Frew, F. Horak, P.K. Keith, C.J. Corrigan, and W. Aberer Ultrashort-specific immunotherapy successfully treats seasonal allergic rhinoconjunctivitis to grass pollen Allergy Asthma Proc 32 2011 239 247
29. O. Pfaar, J. Kleine-Tebbe, K. Hormann, and L. Klimek Allergen-specific immunotherapy: which outcome measures are useful in monitoring clinical trials? Immunol Allergy Clin North Am 31 2011 289 309
30. H.J. Malling Immunotherapy as an effective tool in allergy treatment Allergy 53 1998 461 472
31. G.W. Canonica, C.E. Baena-Cagnani, J. Bousquet, P.J. Bousquet, R.F. Lockey, and H.J. Malling Recommendations for standardization of clinical trials with allergen specific immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce Allergy 62 2007 317 324
32. The COMET Initiative. Available at: http://www.comet-initiative.org/. Accessed February 28, 2012.
33. J. Bousquet, C. Bachert, G.W. Canonica, T.B. Casale, A.A. Cruz, and R.J. Lockey Unmet needs in severe chronic upper airway disease (SCUAD) J Allergy Clin Immunol 124 2009 428 433
34. A. Hróbjartsson, and P.C. Gøtzsche Placebo interventions for all clinical conditions Cochrane Database Syst Rev 2 2004 CD003974
35. National Institute of Allergy and Infectious Diseases (NIAID). Long-term effects of sublingual grass therapy. Available at: http://clinicaltrials.gov/ ct2/show/NCT01335139. Accessed September 6, 2012.